All News

The Food and Drug Administration (FDA) granted a priority review to a biologics license application (BLA) for an immunotherapy agent – cemiplimab – to be used to treat metastatic cutaneous squamous cell carcinoma (a type of skin cancer; CSCC) or patients with locally advanced CSCC who are not eligible for surgery.

When I contemplate this latest benchmark in my life, my 15th year surviving stage 3b breast cancer, I confess there are times when I feel like it was just yesterday the Trickster Coyote – the Native American mythical creature of evil and bad omen – blindsided me, bent on taking me down in the one sacred place I felt I could take refuge from the world: my home.

The Food and Drug Administration (FDA) granted a priority review to a supplemental biologics license application (sBLA) for frontline Keytruda (pembrolizumab) for use in combination with standard chemotherapy for patients with metastatic nonsquamous non–small cell lung cancer (NSCLC), according to Merck (MSD), the manufacturer of the PD-1 inhibitor.

May is skin cancer awareness month, and a good reminder to schedule an appointment with your dermatologist.

This month at CURE, we’re kicking off a social media campaign that gives you the chance to show off your accomplishments, big and small, while inspiring others like you to do the same: Show the world what you #CanDoWithCancer.

Social media can be beneficial in helping survivors connect with others experiencing similar health challenges. Although the benefits haven't been measured, evidence shows strong support for social connectivity.

Nearly 17 years after the terror attack, researchers examine World Trade Center environmental factors and cases of multiple myeloma.

For those of us living with (and taking care of) people living with brain tumors, cancers and other diseases that become chronic, life's challenges begin to shift, as do our outlooks. It is important for us to be able to love our bodies, our disabilities, and for the world to make space for all sorts of bodies to exist.

Writing helped me duck out on cancer.

The National Colorectal Cancer Roundtable has created a special toolkit to help physicians successfully determine and evaluate family history to detect colorectal cancer at an earlier age.

Professional snowboarder Bibian Mentel-Spee inspires through her perseverance despite facing multiple bouts with the disease.

People may tell me that I look good, but I don't always feel that way.

A quality nap can make all the difference.

Recovery from cancer doesn’t just involve physical health; it often involves overcoming the financial barriers between illness and wellness that make moving forward seem impossible.

I have not always been good at respecting others differences. Receiving a cancer diagnosis is one of those times we may all handle life in a different way. My experience taught me a deeper respect for how we process challenges.

Although I was aware of lymphedema, it wasn't really something on my radar screen, until I heard those words.

When you lose six months of your life to battling cancer, you make every moment going forward count.

The combination use of Cyramza (ramucirumab) plus docetaxel showed improvements in objective response rate (ORR) and a positive trend in overall survival (OS) among patients with advanced bladder cancer, according to additional results from the phase 3 RANGE trial.

Age should not limit which patients with metastatic melanoma receive immunotherapy.

Sometimes every little bump or bruise can make me feel terrified of what it might be. Understanding how my brain is wired helps me to fight being overcome with the fear of recurrence.

Don't end up alone lying in the hospital surround by the smells of disinfectant.

Breast cancer survivor with the recently discovered PALB2 genetic mutation talks about what self-care might look like before, during and after her preventative double mastectomy.

So, what was the first thing I thought about when I vowed to not think about cancer? Cancer, of course.

Researchers evaluates microsatellite instability-high status, tumor mutation burden and high PD-L1 expression to determine which grade of tumors would benefit from immunotherapy treatment among women with endometrioid endometrial cancer.

Wishing is fairly commonplace, but can be extremely counterproductive especially in the lives of cancer patients.

The Food and Drug Administration (FDA) approved a next-generation sequencing (NGS) companion diagnostic assay that can detect BRCA1/2 genetic mutations, as well as the percentage of genomic loss of heterozygosity (LOH) in patients with ovarian cancer.

Our dance with cancer is tenuous, so we better lead the way.

Albeit growing popularity of at-home genetic testing, it is still necessary to seek professional medical opinions from genetic counselors to help discuss results.